Adage Capital Partners’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-400,000
| Closed | -$8.94M | – | 781 |
|
|
2019
Q1 | $8.94M | Hold |
400,000
| – | – | 0.02% | 542 |
|
|
2018
Q4 | $9.57M | Buy |
+400,000
| New | +$9.57M | 0.03% | 515 |
|
|
2018
Q2 | – | Sell |
-550,000
| Closed | -$17.5M | – | 813 |
|
|
2018
Q1 | $17.5M | Sell |
550,000
-750,000
| -58% | -$23.9M | 0.04% | 430 |
|
|
2017
Q4 | $49.2M | Sell |
1,300,000
-313,452
| -19% | -$11.9M | 0.11% | 226 |
|
|
2017
Q3 | $40M | Sell |
1,613,452
-286,548
| -15% | -$7.1M | 0.1% | 261 |
|
|
2017
Q2 | $39.1M | Buy |
1,900,000
+658,600
| +53% | +$13.5M | 0.1% | 274 |
|
|
2017
Q1 | $27M | Buy |
1,241,400
+100,000
| +9% | +$2.17M | 0.07% | 343 |
|
|
2016
Q4 | $23.3M | Buy |
1,141,400
+25,000
| +2% | +$511K | 0.06% | 339 |
|
|
2016
Q3 | $16.7M | Hold |
1,116,400
| – | – | 0.05% | 414 |
|
|
2016
Q2 | $12.1M | Sell |
1,116,400
-25,000
| -2% | -$270K | 0.03% | 475 |
|
|
2016
Q1 | $15.5M | Hold |
1,141,400
| – | – | 0.04% | 421 |
|
|
2015
Q4 | $21.1M | Sell |
1,141,400
-100,000
| -8% | -$1.85M | 0.06% | 360 |
|
|
2015
Q3 | $31.4M | Buy |
+1,241,400
| New | +$31.4M | 0.09% | 292 |
|